- Home
- BMO vs ZTS Comparison
BMO vs ZTS Comparison
Compare BMO & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMO
- ZTS
- Stock Information
- Founded
- BMO 1817
- ZTS 1952
- Country
- BMO Canada
- ZTS United States
- Employees
- BMO N/A
- ZTS N/A
- Industry
- BMO Commercial Banks
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- BMO Finance
- ZTS Health Care
- Exchange
- BMO Nasdaq
- ZTS Nasdaq
- Market Cap
- BMO 69.2B
- ZTS 80.4B
- IPO Year
- BMO N/A
- ZTS 2013
- Fundamental
- Price
- BMO $95.77
- ZTS $167.01
- Analyst Decision
- BMO Hold
- ZTS Strong Buy
- Analyst Count
- BMO 5
- ZTS 9
- Target Price
- BMO $122.40
- ZTS $220.33
- AVG Volume (30 Days)
- BMO 745.3K
- ZTS 2.3M
- Earning Date
- BMO 12-05-2024
- ZTS 02-11-2025
- Dividend Yield
- BMO 4.65%
- ZTS 1.03%
- EPS Growth
- BMO 65.10
- ZTS 8.38
- EPS
- BMO 6.82
- ZTS 5.32
- Revenue
- BMO $20,835,306,785.00
- ZTS $9,152,000,000.00
- Revenue This Year
- BMO N/A
- ZTS $9.41
- Revenue Next Year
- BMO $5.50
- ZTS $4.70
- P/E Ratio
- BMO $14.02
- ZTS $31.41
- Revenue Growth
- BMO 7.21
- ZTS 9.33
- 52 Week Low
- BMO $76.98
- ZTS $144.80
- 52 Week High
- BMO $104.63
- ZTS $200.53
- Technical
- Relative Strength Index (RSI)
- BMO 46.48
- ZTS 31.09
- Support Level
- BMO $90.47
- ZTS $175.81
- Resistance Level
- BMO $101.48
- ZTS $181.85
- Average True Range (ATR)
- BMO 2.23
- ZTS 3.84
- MACD
- BMO -0.32
- ZTS -0.51
- Stochastic Oscillator
- BMO 37.43
- ZTS 0.49
About BMO Bank Of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, US P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.